Prescription Required.
Ribavirin is the active ingredient in the medication.It is available in various formulations, including oral capsules, oral solution, and intravenous injection.
Treatment of chronic hepatitis C virus (HCV) infection in combination with other antiviral medications.
Treatment of severe respiratory syncytial virus (RSV) infection in infants and young children.
Ribavin 200mg Cap (Ribavirin) is a nucleoside analog that inhibits the replication of viruses by interfering with the synthesis of viral RNA.
Store Ribavirin at room temperature, away from moisture and direct sunlight.
Keep it out of reach of children.
Do not use Ribavirin after the expiration date printed on the bottle.
The dosage of Ribavirin varies depending on the condition being treated, the patient's age, and other factors.
Your healthcare provider will determine the appropriate dosage for you.
It is important to take Ribavirin exactly as prescribed by your doctor.
Do not miss doses and do not stop taking Ribavirin without talking to your doctor.
Serious side effects can occur, such as heart problems, lung problems, and birth defects.
Common side effects of Ribavirin include anemia, fatigue, nausea, vomiting, diarrhea, and headache.
Avoid alcohol consumption while taking Ribavirin as it may increase the risk of liver damage.
Ribavirin may cause dizziness or fatigue. Avoid driving or operating machinery until you know how Ribavirin affects you.
Ribavirin is known to cause birth defects. It should not be taken by pregnant women or women who are planning to become pregnant.
Ribavirin is not recommended for use in children, especially newborns, due to the risk of serious side effects.
Ribavirin can affect kidney function. People with kidney problems should use Ribavirin with caution.
Ribavirin can affect liver function. People with liver problems should use Ribavirin with caution.
https://www.drugs.com/mtm/ribavirin.html
https://www.webmd.com/drugs/2/drug-12521/ribavirin-oral/details
https://www.ncbi.nlm.nih.gov/pubmed/10739934
https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-ribavirin-associated-birth-defects
